EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieÜbersichtsarbeitValidierungsstudieOpen Access · CC BY 4.0

Predicting Failure at Initiation of High‐Flow Nasal Oxygen in Patients With COVID ‐19: Literature Review, Development and Internal Validation of a Prediction Model

Daphne J T Sjauw, Matthijs L Janssen, Yasemin Türk, Carmen A T Reep, Leo Heunks, Sara J Baart, Evert-Jan Wils iD, Dutch HFNO study group, NORMO2 project group

Respirology · 2026-08 · 31 (8) · 798-807

DOI: 10.1002/resp.70254 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Respirology, online erschienen am 14.04.2026. Verfasst von Daphne J T Sjauw und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Oxygen Inhalation Therapy, COVID-19, Respiratory Insufficiency, Hypoxia. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective High‐Flow Nasal Oxygen (HFNO) can reduce the need for invasive mechanical ventilation in patients with acute hypoxemic respiratory failure (AHRF) from viral pneumonias, like COVID‐19. Early prediction of HFNO failure is useful for timely decision‐making at HFNO initiation. This study aimed to develop a prediction model for HFNO failure using predictors available just prior to HFNO initiation in patients with COVID‐19 AHRF and compare its performance to existing models.

Methods

This multicenter, prospective observational cohort study included hospitalized patients from 10 centers in the Netherlands between December 2020 and July 2021. Adults who tested positive for SARS‐CoV‐2, had no treatment limitations, and initiated HFNO for hypoxemia were included. The primary outcome was HFNO failure, defined as the event of endotracheal intubation. Pre‐defined candidate predictors were selected by multivariable logistic regression for prediction model development. Internal validation was conducted using bootstrapping.

Results

Out of 608 patients, 277 (46%) experienced HFNO failure. Independent predictors of HFNO failure included (odds ratio [95% CI]): age (1.02 [1.00–1.03]), urea (1.04 [1.00–1.08]), platelet count (0.94 [0.92–0.97]), respiratory rate (1.05 [1.02–1.08]), oxygen saturation (0.89 [0.84–0.94]), and FiO 2 (conventional oxygen 10–15 L/min vs. < 10 L/min: 3.00 [1.71–5.29], 15 L/min vs. < 10 L/min: 4.95 [3.19–7.70]) prior to HFNO initiation. The model C‐statistic was 0.767; 95% CI [0.727–0.803], with excellent calibration (intercept: −0.005, slope: 1.001), and stable performance after internal validation.

Conclusions

This newly developed model, using variables available at HFNO initiation, effectively predicted HFNO failure in hospitalized hypoxemic patients due to COVID‐19 pneumonia with good performance. Registration Number Clinical Trial Dutch Trial Registry: DTR, NL9067. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxygen Inhalation TherapyCOVID-19Respiratory InsufficiencyHypoxiaHumansFemaleMaleMiddle AgedProspective StudiesNetherlandsSARS-CoV-2AgedTreatment Failure

Stichwörter der Autor:innen

SARS‐CoV‐2general Wardhigh‐flow nasal oxygenintensive care unitslogistic modelsnon‐invasive ventilationprediction model

Autor:innen und Institutionen

  • Department of Intensive Care, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
  • Department of Intensive Care, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Department of Respiratory Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
  • Department of Intensive Care, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Department of Biostatistics, Erasmus Medical Center, Rotterdam, the Netherlands.

ORCID-Profile: Evert-Jan Wils

Förderung

  • ZonMw

Zitieren

APA

Sjauw, D. J. T., Janssen, M. L., Türk, Y., Reep, C. A. T., Heunks, L., Baart, S. J., Wils, E. J., Dutch HFNO study group, & NORMO2 project group (2026). Predicting Failure at Initiation of High‐Flow Nasal Oxygen in Patients With COVID ‐19: Literature Review, Development and Internal Validation of a Prediction Model. Respirology, 31(8), 798-807. https://doi.org/10.1002/resp.70254

Vancouver

Sjauw DJT, Janssen ML, Türk Y, Reep CAT, Heunks L, Baart SJ, et al. Predicting Failure at Initiation of High‐Flow Nasal Oxygen in Patients With COVID ‐19: Literature Review, Development and Internal Validation of a Prediction Model. Respirology. 2026;31(8):798-807. doi:10.1002/resp.70254

BibTeX
@article{Sjauw2026,
  author = {Sjauw, Daphne J T and Janssen, Matthijs L and Türk, Yasemin and Reep, Carmen A T and Heunks, Leo and Baart, Sara J and Wils, Evert-Jan and Dutch HFNO study group, Dutch HFNO study group and NORMO2 project group, NORMO2 project group},
  title = {Predicting Failure at Initiation of High‐Flow Nasal Oxygen in Patients With COVID ‐19: Literature Review, Development and Internal Validation of a Prediction Model},
  journal = {Respirology},
  year = {2026},
  volume = {31},
  number = {8},
  pages = {798--807},
  doi = {10.1002/resp.70254}
}
Kostenlos starten →